Loading clinical trials...
Loading clinical trials...
Detection of Hypertrophic Cardiomyopathy Using Electrocardiograms and Echocardiograms Through Federated Learning
Conditions
Locations
6
United States
Thomas Hospital
Fairhope, Alabama, United States
Riverside Medical Center
Kankakee, Illinois, United States
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States
University of Michigan Medical Center
Ann Arbor, Michigan, United States
Wooster Community Hospital
Wooster, Ohio, United States
The University of Texas Southwestern Medical Center
Dallas, Texas, United States
Start Date
June 5, 2024
Primary Completion Date
January 1, 2026
Completion Date
January 1, 2026
Last Updated
August 6, 2024
NCT05836259
NCT07054073
NCT07344480
NCT07382128
NCT07372196
NCT07359690
Lead Sponsor
American Heart Association
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions